These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23674107)

  • 21. Vocal Loading and Environmental Humidity Effects in Older Adults.
    Sundarrajan A; Fujiki RB; Loerch SE; Venkatraman A; Sivasankar MP
    J Voice; 2017 Nov; 31(6):707-713. PubMed ID: 28238589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychological and somatic predictors of perceived and measured ocular dryness of patients with primary Sjögren's syndrome.
    Vriezekolk JE; Geenen R; Hartkamp A; Godaert GL; Bootsma H; Kruize AA; Bijlsma JW; Derksen RH
    J Rheumatol; 2005 Dec; 32(12):2351-5. PubMed ID: 16331762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phonatory effects of airway dehydration: preliminary evidence for impaired compensation to oral breathing in individuals with a history of vocal fatigue.
    Sivasankar M; Erickson E; Schneider S; Hawes A
    J Speech Lang Hear Res; 2008 Dec; 51(6):1494-506. PubMed ID: 18664688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing the negative vocal effects of superficial laryngeal dehydration with humidification.
    Levendoski EE; Sundarrajan A; Sivasankar MP
    Ann Otol Rhinol Laryngol; 2014 Jul; 123(7):475-81. PubMed ID: 24690983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal esophageal motility in primary Sjögren's syndrome.
    Ramirez-Mata M; Pena Ancira FF; Alarcon-Segovia D
    J Rheumatol; 1976 Mar; 3(1):63-9. PubMed ID: 1271390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The management of Sjögren's syndrome.
    Mavragani CP; Moutsopoulos NM; Moutsopoulos HM
    Nat Clin Pract Rheumatol; 2006 May; 2(5):252-61. PubMed ID: 16932698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review and update of Sjögren's syndrome: manifestations, diagnosis, and treatment.
    Carsons S
    Am J Manag Care; 2001 Sep; 7(14 Suppl):S433-43. PubMed ID: 11605978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient selection criteria for electrostimulation of salivary production in the treatment of xerostomia secondary to Sjogren's syndrome.
    Erlichman M
    Health Technol Assess Rep; 1990; (8):1-7. PubMed ID: 1369638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-duration accelerated breathing challenges affect phonation.
    Sivasankar M; Erickson E
    Laryngoscope; 2009 Aug; 119(8):1658-63. PubMed ID: 19522007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence and risk factors for occupational voice disorders in teachers.
    Sliwinska-Kowalska M; Niebudek-Bogusz E; Fiszer M; Los-Spychalska T; Kotylo P; Sznurowska-Przygocka B; Modrzewska M
    Folia Phoniatr Logop; 2006; 58(2):85-101. PubMed ID: 16479131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of neuromuscular electrical stimulation in a patient with Sjogren's syndrome with dysphagia: a real time videofluoroscopic swallowing study.
    Cheung SM; Chen CJ; Hsin YJ; Tsai YT; Leong CP
    Chang Gung Med J; 2010; 33(3):338-45. PubMed ID: 20584513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scoping review of the relationship between xerostomia and voice quality.
    Saghiri MA; Vakhnovetsky A; Vakhnovetsky J
    Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3087-3095. PubMed ID: 36995371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.
    Pillemer SR; Brennan MT; Sankar V; Leakan RA; Smith JA; Grisius M; Ligier S; Radfar L; Kok MR; Kingman A; Fox PC
    Arthritis Rheum; 2004 Aug; 51(4):601-4. PubMed ID: 15334433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of the oral features of Sjögren's syndrome.
    Gravenmade EJ; Vissink A
    Neth J Med; 1992 Apr; 40(3-4):117-24. PubMed ID: 1603201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of formula ophiopogoins in the treatment of xerostomia and pharyngoxerosis.
    Sugano S; Takeyama I; Ogino S; Kenmochi M; Kaneko T
    Acta Otolaryngol Suppl; 1996; 522():124-9. PubMed ID: 8740826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laryngeal findings and voice quality in Sjögren's syndrome.
    Ogut F; Midilli R; Oder G; Engin EZ; Karci B; Kabasakal Y
    Auris Nasus Larynx; 2005 Dec; 32(4):375-80. PubMed ID: 16095856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye.
    Vitale S; Goodman LA; Reed GF; Smith JA
    Health Qual Life Outcomes; 2004 Sep; 2():44. PubMed ID: 15341657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties.
    Gøransson LG; Haldorsen K; Brun JG; Harboe E; Jonsson MV; Skarstein K; Time K; Omdal R
    Scand J Rheumatol; 2011 May; 40(3):221-4. PubMed ID: 21231797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sjögren's syndrome: challenges to management.
    Jabs DA
    Am J Manag Care; 2001 Sep; 7(14 Suppl):S431-2. PubMed ID: 11605977
    [No Abstract]   [Full Text] [Related]  

  • 40. Optimizing dry mouth treatment for individuals with Sjögren's syndrome.
    Wu AJ
    Rheum Dis Clin North Am; 2008 Nov; 34(4):1001-10, x. PubMed ID: 18984418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.